~~<i id='C22B8E82A4'><strike id='C22B8E82A4'><tt id='C22B8E82A4'><pre id='C22B8E82A4'></pre></tt></strike></i>~~

Home» leisure time» hotspot

hotspot

author：focus 2025-09-28 15:12:46 Page View：5749

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Device maker Teleflex to acquire urology company for $600M
Next article： Drug repurposing or repositioning? The language matters

leisure time

Malaria cases in Florida and Texas: Here’s what you need to know

MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

Biden warns of ‘dark winter’ during final presidental debate

DemocraticpresidentialcandidateformerVicePresidentJoeBidenanswersaquestionasPresidentTrumplistensdur

Apple is now the first public company to be valued at $3 trillion

6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

Kidney transplant patients stopped immunosuppressants in trial

BRENDANSMIALOWSKI/AFP/GettyImagesKidneytransplantsarethemostcommonorgantransplantprocedureintheU.S.,

WSS

hotspot

hotspot

explore

leisure time

Kidney transplant patients stopped immunosuppressants in trial